{"id":1624,"date":"2024-06-15T01:13:16","date_gmt":"2024-06-15T01:13:16","guid":{"rendered":"https:\/\/healthmedicinet.com\/review\/study-reveals-novel-immune-based-biomarker-helps-detect-ovarian-cancer-years-before-conventional-diagnosis\/"},"modified":"2024-06-15T01:13:16","modified_gmt":"2024-06-15T01:13:16","slug":"study-reveals-novel-immune-based-biomarker-helps-detect-ovarian-cancer-years-before-conventional-diagnosis","status":"publish","type":"post","link":"https:\/\/healthmedicinet.com\/review\/study-reveals-novel-immune-based-biomarker-helps-detect-ovarian-cancer-years-before-conventional-diagnosis\/","title":{"rendered":"Study reveals novel immune-based biomarker helps detect ovarian cancer years before conventional diagnosis"},"content":{"rendered":"<p>Graphical abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016\/j.xcrm.2024.101612 Researchers at Children&#8217;s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The findings were published today in the journal Cell Reports Medicine. High-grade ovarian cancer (HGOC) is the fifth-leading cause of cancer-related death among women. More than 90% of women are diagnosed when the disease has reached advanced stages and has already spread, presenting significant treatment challenges. Ovarian cancer is highly treatable <a class=\"read-more-link\" href=\"https:\/\/healthmedicinet.com\/study-reveals-novel-immune-based-biomarker-helps-detect-ovarian-cancer-years-before-conventional-diagnosis\/\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Graphical abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016\/j.xcrm.2024.101612 Researchers at Children&#8217;s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The findings were published today in the journal Cell Reports Medicine. High-grade ovarian cancer (HGOC) is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1624","post","type-post","status-publish","format-standard","hentry","category-health-news"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/posts\/1624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/comments?post=1624"}],"version-history":[{"count":0,"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/posts\/1624\/revisions"}],"wp:attachment":[{"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/media?parent=1624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/categories?post=1624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthmedicinet.com\/review\/wp-json\/wp\/v2\/tags?post=1624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}